Therapeutic Asset Ratings
462 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Brivestobart
Neoplasm
Guangzhou Gloria Biosciences Co., Ltd.
P1/2
CC
(40)
c019199
Neoplasm
Fujian Haixi Pharmaceuticals Co., Ltd.
P1/2
CC
(40)
CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE
Neoplasm
Eisai Inc.
P1/2
CC
(40)
Cmts1215 Oncolytic Bacteria
Neoplasm
The Second Hospital of Nanjing Medical University
P1/2
CC
(40)
Crb-601 Monoclonal Antibody
Neoplasm
Corbus Pharmaceuticals Inc.
P1/2
CC
(40)
cts3497
Neoplasm
CytosinLab Therapeutics Co., Ltd.
P1/2
CC
(40)
Donafenib
Neoplasm
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
P1/2
CC
(40)
Fog-001
Neoplasm
Parabilis Medicines, Inc.
P1/2
CC
(40)
Fosdesdenosine Sipalabenamide
Neoplasm
NuCana plc
P1/2
CC
(40)
Gallium-68 Labelled Fap-2286
Neoplasm
Novartis Pharmaceuticals
P1/2
CC
(40)
Garsorasib
Neoplasm
InventisBio Co., Ltd
P1/2
CC
(40)
gfs101a
Neoplasm
Zhejiang Genfleet Therapeutics Co., Ltd.
P1/2
CC
(40)
Gim-531
Neoplasm
Georgiamune Inc
P1/2
CC
(40)
Gls-010
Neoplasm
Guangzhou Gloria Biosciences Co., Ltd.
P1/2
CC
(40)
gsk4418959
Neoplasm
GlaxoSmithKline
P1/2
CC
(40)
Hla-G-Car.Bite Allogeneic Γδ T Cells
Neoplasm
Ever Supreme Bio Technology Co., Ltd.
P1/2
CC
(40)
Hrs-8364
Neoplasm
Jiangsu HengRui Medicine Co., Ltd.
P1/2
CC
(40)
hs-10365
Neoplasm
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P1/2
CC
(40)
ibi130
Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.
P1/2
CC
(40)
ibi3004
Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.
P1/2
CC
(40)
ibi3005
Neoplasm
Innovent Biologics (Suzhou) Co. Ltd.
P1/2
CC
(40)
imm01
Neoplasm
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
P1/2
CC
(40)
Immunoglobulin G1-kappa, anti-[Homo sapiens MET (met proto-oncogene, hepatocyte growth factor (HGF) receptor, HGFR, scatter factor (SF) receptor, HGF/SF receptor, receptor tyrosine-protein kinase c-met, papillary renal cell carcinoma 2, RCCP2)] and anti-[Homo sapiens EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB)], Homo sapiens monoclonal antibody, bispecific
Neoplasm
Betta Pharmaceuticals Co., Ltd.
P1/2
CC
(40)
imp9064
Neoplasm
Impact Therapeutics, Inc.
P1/2
CC
(40)
Inbrx-106
Neoplasm
Inhibrx Biosciences, Inc
P1/2
CC
(40)
Showing 151 to 175 of 462 assets
Previous
Page 7 of 19
Next
